Clinical Trial Update: Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for prevention of TRAGI in extremely low gestational age neonates using inhaled nitric oxide (iNO) in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Prematurity
• Transfusion-related Acute Gut Injury

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: New York Medical College | Conditions: Anemia | Phase 1, Phase 2 | Status: UNKNOWN